152
Views
0
CrossRef citations to date
0
Altmetric
CASE SERIES

Ribociclib Plus Letrozole in Italian Male Patients with Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Case Studies of Phase 3b CompLEEment-1 Trial

, , , , , ORCID Icon & ORCID Icon show all
Pages 351-362 | Received 01 Jun 2022, Accepted 09 Aug 2022, Published online: 04 Dec 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.